Implementation and Effectiveness of Engagement and Collaborative Management to Proactively Advance Sepsis Survivorship

NACompletedINTERVENTIONAL
Enrollment

3,894

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

April 1, 2024

Study Completion Date

April 1, 2024

Conditions
Sepsis
Interventions
BEHAVIORAL

Sepsis Transition and Recovery (STAR) program

In the STAR program intervention, a centrally located nurse navigator facilitates the application of four evidence-based core components of post-sepsis care (i.e., review of medications, new impairments, comorbidities, and palliative care) to patients prior to and during the 90 days after hospital discharge. The STAR navigator will provide telephone and EHR-based support within the hospitalization and to patients across all discharge settings with remote monitoring at specified intervals following hospital discharge. Patients will continue to receive STAR directed services for 90 days following their discharge and then will be transitioned back to the next appropriate care location.

BEHAVIORAL

Usual care

Hospitals and their patients will not have access to the STAR program. Patients will continue to receive usual care throughout their stay and discharge, consisting of: patient education and follow-up instructions at discharge, which are not specific to sepsis; routine recommendations for follow-up visits with primary care providers; arrangements for home health services or care management follow-up based on each patient's needs but not specifically tailored to the sepsis population; discharge to post-acute setting with no sepsis-specific follow-up. All aspects of usual care will be determined by treating clinicians independent of trial assignment.

Trial Locations (1)

28203

Atrium Health, Charlotte

All Listed Sponsors
collaborator

National Institute of Nursing Research (NINR)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT04495946 - Implementation and Effectiveness of Engagement and Collaborative Management to Proactively Advance Sepsis Survivorship | Biotech Hunter | Biotech Hunter